{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T13:29:02Z","timestamp":1787232542358,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05444-9","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T15:34:33Z","timestamp":1781364873000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Parasite based biotherapy for cancer therapeutic strategies and preclinical applications"],"prefix":"10.1007","volume":"17","author":[{"given":"Rahim","family":"Mehdioghli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Chavshin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Bakhshipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haleh","family":"Hanifian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"issue":"2","key":"5444_CR1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.14216\/kjco.24009","volume":"20","author":"S Ahuja","year":"2024","unstructured":"Ahuja S, Zaheer S. The evolution of cancer immunotherapy: a comprehensive review of its history and current perspectives. Korean J Clin Oncol. 2024;20(2):51\u201373. https:\/\/doi.org\/10.14216\/kjco.24009.","journal-title":"Korean J Clin Oncol"},{"issue":"2","key":"5444_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","volume":"124","author":"H Raskov","year":"2021","unstructured":"Raskov H, Orhan A, Christensen JP, G\u00f6genur I. Cytotoxic CD8\u2009+\u2009T cells in cancer and cancer immunotherapy. Br J Cancer. 2021;124(2):359\u201367. https:\/\/doi.org\/10.1038\/s41416-020-01048-4.","journal-title":"Br J Cancer"},{"issue":"5","key":"5444_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nri.2017.142","volume":"18","author":"K Taniguchi","year":"2018","unstructured":"Taniguchi K, Karin M. NF-\u03baB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018;18(5):309\u201324. https:\/\/doi.org\/10.1038\/nri.2017.142.","journal-title":"Nat Rev Immunol"},{"issue":"13","key":"5444_CR4","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1158\/0008-5472.CAN-12-1974","volume":"73","author":"JR Baird","year":"2013","unstructured":"Baird JR, Fox BA, Sanders KL, et al. Avirulent Toxoplasma gondii generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironment. Cancer Res. 2013;73(13):3842\u201351. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-1974.","journal-title":"Cancer Res"},{"issue":"2","key":"5444_CR5","doi-asserted-by":"publisher","first-page":"e1963","DOI":"10.1002\/cnr2.1963","volume":"7","author":"N Lotfalizadeh","year":"2024","unstructured":"Lotfalizadeh N, Sadr S, Morovati S, Lotfalizadeh M, Hajjafari A, Borji H. A potential cure for tumor-associated immunosuppression by Toxoplasma gondii. Cancer Rep (Hoboken). 2024;7(2):e1963. https:\/\/doi.org\/10.1002\/cnr2.1963.","journal-title":"Cancer Rep (Hoboken)"},{"issue":"5","key":"5444_CR6","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.immuni.2018.10.016","volume":"49","author":"RM Maizels","year":"2018","unstructured":"Maizels RM, Smits HH, McSorley HJ. Modulation of host immunity by helminths: the expanding repertoire of parasite effector molecules. Immunity. 2018;49(5):801\u201318. https:\/\/doi.org\/10.1016\/j.immuni.2018.10.016.","journal-title":"Immunity"},{"issue":"3","key":"5444_CR7","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jaci.2016.07.007","volume":"138","author":"RM Maizels","year":"2016","unstructured":"Maizels RM, McSorley HJ. Regulation of the host immune system by helminth parasites. J Allergy Clin Immunol. 2016;138(3):666\u201375. https:\/\/doi.org\/10.1016\/j.jaci.2016.07.007.","journal-title":"J Allergy Clin Immunol"},{"key":"5444_CR8","doi-asserted-by":"publisher","first-page":"824695","DOI":"10.3389\/fimmu.2022.824695","volume":"13","author":"K Nagai","year":"2022","unstructured":"Nagai K, Goto Y. Parasitomimetics: can we utilize parasite-derived immunomodulatory molecules for interventions to immunological disorders? Front Immunol. 2022;13:824695. https:\/\/doi.org\/10.3389\/fimmu.2022.824695.","journal-title":"Front Immunol"},{"key":"5444_CR9","doi-asserted-by":"publisher","first-page":"107684","DOI":"10.1016\/j.actatropica.2025.107684","volume":"267","author":"YW Chua","year":"2025","unstructured":"Chua YW, Chow SC. Bug as a drug: unveiling anti-cancer properties of Toxoplasma gondii and its therapeutic prospects in cancer immunotherapy. Acta Trop. 2025;267:107684. https:\/\/doi.org\/10.1016\/j.actatropica.2025.107684.","journal-title":"Acta Trop"},{"issue":"2","key":"5444_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4161\/viru.1.2.10487","volume":"1","author":"MC Botelho","year":"2010","unstructured":"Botelho MC, Machado JC, da Costa JM. Schistosoma haematobium and bladder cancer: what lies beneath? Virulence. 2010;1(2):84\u20137. https:\/\/doi.org\/10.4161\/viru.1.2.10487.","journal-title":"Virulence"},{"issue":"8","key":"5444_CR11","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1046\/j.1365-2168.2002.02143.x","volume":"89","author":"P Watanapa","year":"2002","unstructured":"Watanapa P, Watanapa WB. Liver fluke-associated cholangiocarcinoma. Br J Surg. 2002;89(8):962\u201370. https:\/\/doi.org\/10.1046\/j.1365-2168.2002.02143.x.","journal-title":"Br J Surg"},{"issue":"6","key":"5444_CR12","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3892\/mmr.2021.12057","volume":"23","author":"Y Liang","year":"2021","unstructured":"Liang Y, Chen X, Tao Z, et al. Plasmodium infection prevents recurrence and metastasis of hepatocellular carcinoma possibly via inhibition of the epithelial-mesenchymal transition. Mol Med Rep. 2021;23(6):418. https:\/\/doi.org\/10.3892\/mmr.2021.12057.","journal-title":"Mol Med Rep"},{"key":"5444_CR13","doi-asserted-by":"publisher","first-page":"959300","DOI":"10.3389\/fcimb.2022.959300","volume":"12","author":"J Chen","year":"2022","unstructured":"Chen J, Liao W, Peng H. Toxoplasma gondii infection possibly reverses host immunosuppression to restrain tumor growth. Front Cell Infect Microbiol. 2022;12:959300. https:\/\/doi.org\/10.3389\/fcimb.2022.959300.","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"5444_CR14","first-page":"481","volume":"144","author":"FT Silveira","year":"2017","unstructured":"Silveira FT, Faria DR, Marinho FA, et al. Leishmania major infection suppresses fibrosarcoma growth via immune activation. Parasitology. 2017;144(4):481\u201396.","journal-title":"Parasitology"},{"key":"5444_CR15","doi-asserted-by":"publisher","first-page":"106172","DOI":"10.1016\/j.actatropica.2021.106172","volume":"225","author":"J Ding","year":"2022","unstructured":"Ding J, Tang B, Liu X, et al. Excretory-secretory product of Trichinella spiralis inhibits tumor cell growth by regulating the immune response and inducing apoptosis. Acta Trop. 2022;225:106172. https:\/\/doi.org\/10.1016\/j.actatropica.2021.106172.","journal-title":"Acta Trop"},{"issue":"6","key":"5444_CR16","doi-asserted-by":"publisher","first-page":"e351","DOI":"10.1038\/oncsis.2017.52","volume":"6","author":"Y Yang","year":"2017","unstructured":"Yang Y, Liu Q, Lu J, et al. Exosomes from Plasmodium-infected hosts inhibit tumor angiogenesis in a murine Lewis lung cancer model. Oncogenesis. 2017;6(6):e351. https:\/\/doi.org\/10.1038\/oncsis.2017.52.","journal-title":"Oncogenesis"},{"issue":"5","key":"5444_CR17","doi-asserted-by":"publisher","first-page":"e13035","DOI":"10.1111\/pim.13035","volume":"46","author":"SS Younis","year":"2024","unstructured":"Younis SS, Salama AM, Elmehy DA, et al. Trichinella spiralis larval extract as a biological anti-tumor therapy in a murine model of Ehrlich solid carcinoma. Parasite Immunol. 2024;46(5):e13035. https:\/\/doi.org\/10.1111\/pim.13035.","journal-title":"Parasite Immunol"},{"issue":"5","key":"5444_CR18","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.meegid.2007.06.004","volume":"7","author":"A Crampton","year":"2007","unstructured":"Crampton A, Vanniasinkam T. Parasite vaccines: the new generation. Infect Genet Evol. 2007;7(5):664\u201373. https:\/\/doi.org\/10.1016\/j.meegid.2007.06.004.","journal-title":"Infect Genet Evol"},{"issue":"1","key":"5444_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12964-020-00570-5","volume":"18","author":"B Wang","year":"2020","unstructured":"Wang B, Li Q, Wang J, et al. Plasmodium infection inhibits tumor angiogenesis through effects on tumor-associated macrophages in a murine implanted hepatoma model. Cell Commun Signal. 2020;18(1):157. https:\/\/doi.org\/10.1186\/s12964-020-00570-5.","journal-title":"Cell Commun Signal"},{"key":"5444_CR20","doi-asserted-by":"publisher","first-page":"1724792","DOI":"10.3389\/fmolb.2025.1724792","volume":"12","author":"Q Huang","year":"2026","unstructured":"Huang Q, Yang D, Tao Z, et al. Plasmodium infection fully activates the immune system in peripheral blood and tumor microenvironment in a murine Lewis lung cancer model. Front Mol Biosci. 2026;12:1724792. https:\/\/doi.org\/10.3389\/fmolb.2025.1724792. Published 2026 Jan 28.","journal-title":"Front Mol Biosci"},{"key":"5444_CR21","doi-asserted-by":"publisher","first-page":"1181176","DOI":"10.3389\/fonc.2023.1181176","volume":"13","author":"X Chen","year":"2023","unstructured":"Chen X, Tao Z, Liang Y, et al. Plasmodium immunotherapy combined with gemcitabine has a synergistic inhibitory effect on tumor growth and metastasis in murine Lewis lung cancer models. Front Oncol. 2023;13:1181176. https:\/\/doi.org\/10.3389\/fonc.2023.1181176.","journal-title":"Front Oncol"},{"issue":"22","key":"5444_CR22","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.3390\/cells11223600","volume":"11","author":"Z Tao","year":"2022","unstructured":"Tao Z, Ding W, Cheng Z, et al. Preclinical study of Plasmodium immunotherapy combined with radiotherapy for solid tumors. Cells. 2022;11(22):3600. https:\/\/doi.org\/10.3390\/cells11223600.","journal-title":"Cells"},{"issue":"1","key":"5444_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3347\/PHD.24082","volume":"63","author":"BK Kim","year":"2025","unstructured":"Kim BK, Choi HG, Lee JH, et al. Anti-tumor effects of Toxoplasma gondii and antigen-pulsed dendritic cells in mice bearing breast cancer. Parasites Hosts Dis. 2025;63(1):37\u201349. https:\/\/doi.org\/10.3347\/PHD.24082.","journal-title":"Parasites Hosts Dis"},{"issue":"1","key":"5444_CR24","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12935-024-03333-1","volume":"24","author":"H Ye","year":"2024","unstructured":"Ye H, Zhou X, Zhu B, et al. Toxoplasma gondii suppresses proliferation and migration of breast cancer cells by regulating their transcriptome. Cancer Cell Int. 2024;24(1):144. https:\/\/doi.org\/10.1186\/s12935-024-03333-1.","journal-title":"Cancer Cell Int"},{"issue":"7","key":"5444_CR25","doi-asserted-by":"publisher","first-page":"e1006189","DOI":"10.1371\/journal.pgen.1006189","volume":"12","author":"BA Fox","year":"2016","unstructured":"Fox BA, Sanders KL, Rommereim LM, et al. Secretion of rhoptry and dense granule effector proteins by nonreplicating Toxoplasma gondii uracil auxotrophs controls the development of antitumor immunity. PLoS Genet. 2016;12(7):e1006189. https:\/\/doi.org\/10.1371\/journal.pgen.1006189.","journal-title":"PLoS Genet"},{"issue":"3","key":"5444_CR26","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3390\/biomedicines13030665","volume":"13","author":"PS Bruno","year":"2025","unstructured":"Bruno PS, Biggers P, Nuru N, et al. Small biological fighters against cancer: viruses, bacteria, archaea, fungi, protozoa, and microalgae. Biomedicines. 2025;13(3):665. https:\/\/doi.org\/10.3390\/biomedicines13030665.","journal-title":"Biomedicines"},{"issue":"1","key":"5444_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13027-026-00747-6","volume":"21","author":"MM Eissa","year":"2026","unstructured":"Eissa MM, Ali NAF, El Skhawy N. Glancing at the role of Toxoplasma gondii in neuro-oncology: from risk factor to therapeutic target. Infect Agent Cancer. 2026;21(1):30. https:\/\/doi.org\/10.1186\/s13027-026-00747-6.","journal-title":"Infect Agent Cancer"},{"key":"5444_CR28","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.2147\/IDR.S523180","volume":"18","author":"S Usluca","year":"2025","unstructured":"Usluca S, Bakir A, Arikok AT, Korkut G, Yagiz GC, Alper M. Detection of Toxoplasma gondii and high-risk human papillomaviruses in FFPE malignant and benign breast lesions using real-time PCR. Infect Drug Resist. 2025;18:3149\u201355. https:\/\/doi.org\/10.2147\/IDR.S523180.","journal-title":"Infect Drug Resist"},{"key":"5444_CR29","doi-asserted-by":"publisher","first-page":"1737423","DOI":"10.3389\/fonc.2025.1737423","volume":"15","author":"H Cai","year":"2026","unstructured":"Cai H, Yang S, Wang R, et al. The pathogen\u2019s playbook in cancer: from oncogenesis to progression. Front Oncol. 2026;15:1737423. https:\/\/doi.org\/10.3389\/fonc.2025.1737423.","journal-title":"Front Oncol"},{"key":"5444_CR30","doi-asserted-by":"publisher","first-page":"672222","DOI":"10.3389\/fimmu.2021.672222","volume":"12","author":"M Ghorbani","year":"2021","unstructured":"Ghorbani M, Khamesipour A, Seyed N, et al. Attenuated Leishmania tarentolae as a vaccine vector against melanoma and colon cancer: immune responses and tumor inhibition in mice. Front Immunol. 2021;12:672222. https:\/\/doi.org\/10.3389\/fimmu.2021.672222.","journal-title":"Front Immunol"},{"issue":"6","key":"5444_CR31","first-page":"2459","volume":"110","author":"MM Eissa","year":"2012","unstructured":"Eissa MM, Sallam SM, Abdel-Halim MS, et al. Apoptotic effect of Trichinella spiralis excretory-secretory products on human hepatocellular carcinoma cells. Parasitol Res. 2012;110(6):2459\u201364.","journal-title":"Parasitol Res"},{"key":"5444_CR32","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3389\/fimmu.2012.00370","volume":"3","author":"U Krzych","year":"2012","unstructured":"Krzych U, Dalai S, Zarling S, Pichugin A. Memory CD8 T cells specific for plasmodia liver-stage antigens maintain protracted protection against malaria. Front Immunol. 2012;3:370. https:\/\/doi.org\/10.3389\/fimmu.2012.00370.","journal-title":"Front Immunol"},{"issue":"9","key":"5444_CR33","first-page":"4909","volume":"14","author":"M Nasiri","year":"2013","unstructured":"Nasiri M, Mohammadzadeh M, Mobedi I, et al. Antitumor effects of Echinococcus granulosus hydatid cyst fluid on breast and colon cancer models. Asian Pac J Cancer Prev. 2013;14(9):4909\u201314.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"5444_CR34","first-page":"13","volume":"26","author":"NM El-Bahy","year":"2014","unstructured":"El-Bahy NM, Ramadan MA, Abdel Rahman HA. Antiangiogenic and pro-apoptotic effects of Echinococcus granulosus antigen on colon cancer. J Egypt Natl Canc Inst. 2014;26(1):13\u201321.","journal-title":"J Egypt Natl Canc Inst"},{"issue":"6","key":"5444_CR35","first-page":"453","volume":"33","author":"JL Reyes","year":"2011","unstructured":"Reyes JL, Terrazas LI, Satoskar AR. Immunomodulatory effects of Taenia crassiceps infection on melanoma growth in mice. Parasite Immunol. 2011;33(6):453\u201362.","journal-title":"Parasite Immunol"},{"issue":"3","key":"5444_CR36","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/CMR.0b013e3282feeaab","volume":"18","author":"VD Atayde","year":"2008","unstructured":"Atayde VD, Jasiulionis MG, Cortez M, Yoshida N. A recombinant protein based on Trypanosoma cruzi surface molecule gp82 induces apoptotic cell death in melanoma cells. Melanoma Res. 2008;18(3):172\u201383. https:\/\/doi.org\/10.1097\/CMR.0b013e3282feeaab.","journal-title":"Melanoma Res"},{"key":"5444_CR37","first-page":"39640496","volume":"12","author":"M Serrano-Rodr\u00edguez","year":"2024","unstructured":"Serrano-Rodr\u00edguez M, Arias-Montano JA, Cruz-Cruz C, et al. Trypanosoma cruzi calcineurin B subunit inhibits proliferation and induces apoptosis in melanoma and cervical adenocarcinoma cells. Front Cell Dev Biol. 2024;12:39640496. PMID: 39640496.","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"5444_CR38","doi-asserted-by":"publisher","first-page":"e95457","DOI":"10.1371\/journal.pone.0095457","volume":"9","author":"L Aguilar-Guzm\u00e1n","year":"2014","unstructured":"Aguilar-Guzm\u00e1n L, Lobos-Gonz\u00e1lez L, Rosas C, et al. Human survivin and Trypanosoma cruzi calreticulin act in synergy against a murine melanoma in vivo. PLoS ONE. 2014;9(4):e95457. https:\/\/doi.org\/10.1371\/journal.pone.0095457.","journal-title":"PLoS ONE"},{"issue":"7","key":"5444_CR39","doi-asserted-by":"publisher","first-page":"e730","DOI":"10.1371\/journal.pntd.0000730","volume":"4","author":"NC L\u00f3pez","year":"2010","unstructured":"L\u00f3pez NC, Valck C, Ram\u00edrez G, et al. Antiangiogenic and antitumor effects of Trypanosoma cruzi calreticulin. PLoS Negl Trop Dis. 2010;4(7):e730. https:\/\/doi.org\/10.1371\/journal.pntd.0000730.","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"5444_CR40","doi-asserted-by":"publisher","first-page":"e36245","DOI":"10.1371\/journal.pone.0036245","volume":"7","author":"C Junqueira","year":"2012","unstructured":"Junqueira C, Guerrero AT, Galv\u00e3o-Filho B, et al. Trypanosoma cruzi adjuvants potentiate T cell-mediated immunity induced by a NY-ESO-1 based antitumor vaccine. PLoS ONE. 2012;7(5):e36245. https:\/\/doi.org\/10.1371\/journal.pone.0036245.","journal-title":"PLoS ONE"},{"issue":"Pt 10","key":"5444_CR41","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1242\/jcs.02934","volume":"119","author":"L Kim","year":"2006","unstructured":"Kim L, Denkers EY. Toxoplasma gondii triggers Gi-dependent PI3-kinase signaling required for inhibition of host cell apoptosis. J Cell Sci. 2006;119(Pt 10):2119\u201326. https:\/\/doi.org\/10.1242\/jcs.02934.","journal-title":"J Cell Sci"},{"issue":"1","key":"5444_CR42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1051\/parasite\/2003101p59","volume":"10","author":"A Val\u00e8re","year":"2003","unstructured":"Val\u00e8re A, Garnotel R, Villena I, Guenounou M, Pinon JM, Aubert D. Activation of the cellular mitogen-activated protein kinase pathways ERK, P38 and JNK during Toxoplasma gondii invasion. Parasite. 2003;10(1):59\u201364. https:\/\/doi.org\/10.1051\/parasite\/2003101p59.","journal-title":"Parasite"},{"issue":"2","key":"5444_CR43","first-page":"240","volume":"17","author":"A Vafae Eslahi","year":"2022","unstructured":"Vafae Eslahi A, Ghaffarifar F, Hassan ZM, Dalimi A. Anticancer activity of hydatid cyst fluid along with antigen B on tumors induced by 4T1 breast cancer cells in a BALB\/c mouse model. Iran J Parasitol. 2022;17(2):240\u20139.","journal-title":"Iran J Parasitol"},{"issue":"9","key":"5444_CR44","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1128\/IAI.00174-16","volume":"84","author":"PB Narasimhan","year":"2016","unstructured":"Narasimhan PB, Bennuru S, Meng Z, et al. Microfilariae of Brugia malayi inhibit the mTOR pathway and induce autophagy in human dendritic cells. Infect Immun. 2016;84(9):2463\u201372. https:\/\/doi.org\/10.1128\/IAI.00174-16.","journal-title":"Infect Immun"},{"issue":"2","key":"5444_CR45","doi-asserted-by":"publisher","first-page":"8","DOI":"10.32604\/or.2025.071891","volume":"34","author":"M Paw\u0142owska","year":"2026","unstructured":"Paw\u0142owska M, Jarek D, Milanowski J, Szewczyk-Golec K. Parasitic infections and carcinogenesis: molecular mechanisms, immune modulation, and emerging therapeutic strategies. Oncol Res. 2026;34(2):8. https:\/\/doi.org\/10.32604\/or.2025.071891.","journal-title":"Oncol Res"},{"key":"5444_CR46","doi-asserted-by":"publisher","first-page":"102368","DOI":"10.1016\/j.parint.2021.102368","volume":"83","author":"F Ihara","year":"2021","unstructured":"Ihara F, Nishikawa Y. Toxoplasma gondii manipulates host cell signaling pathways via its secreted effector molecules. Parasitol Int. 2021;83:102368. https:\/\/doi.org\/10.1016\/j.parint.2021.102368.","journal-title":"Parasitol Int"},{"issue":"6","key":"5444_CR47","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry EJ. T cell exhaustion. Nat Immunol. 2011;12(6):492\u20139. https:\/\/doi.org\/10.1038\/ni.2035.","journal-title":"Nat Immunol"},{"issue":"9","key":"5444_CR48","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","volume":"8","author":"SC Wei","year":"2018","unstructured":"Wei SC, Duffy CR, Allison JP. Fundamental mechanisms of immune checkpoint blockade therapy. Cancer Discov. 2018;8(9):1069\u201386. https:\/\/doi.org\/10.1158\/2159-8290.CD-18-0367.","journal-title":"Cancer Discov"},{"issue":"1","key":"5444_CR49","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s40425-018-0381-3","volume":"6","author":"NS Forbes","year":"2018","unstructured":"Forbes NS, Coffin RS, Deng L, et al. White paper on microbial anti-cancer therapy and prevention. J Immunother Cancer. 2018;6(1):78. https:\/\/doi.org\/10.1186\/s40425-018-0381-3.","journal-title":"J Immunother Cancer"},{"issue":"7","key":"5444_CR50","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nbt.2287","volume":"30","author":"SJ Russell","year":"2012","unstructured":"Russell SJ, Peng KW, Bell JC. Oncolytic virotherapy. Nat Biotechnol. 2012;30(7):658\u201370. https:\/\/doi.org\/10.1038\/nbt.2287.","journal-title":"Nat Biotechnol"},{"issue":"3","key":"5444_CR51","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","volume":"18","author":"RS Riley","year":"2019","unstructured":"Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019;18(3):175\u201396. https:\/\/doi.org\/10.1038\/s41573-018-0006-z.","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"5444_CR52","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.pt.2015.06.009","volume":"31","author":"G Coakley","year":"2015","unstructured":"Coakley G, Maizels RM, Buck AH. Exosomes and other extracellular vesicles: the new communicators in parasite infections. Trends Parasitol. 2015;31(10):477\u201389. https:\/\/doi.org\/10.1016\/j.pt.2015.06.009.","journal-title":"Trends Parasitol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05444-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05444-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05444-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T13:02:50Z","timestamp":1787230970000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05444-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5444"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05444-9","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1217"}}